Baker Bros. Advisors as of June 30, 2019
Portfolio Holdings for Baker Bros. Advisors
Baker Bros. Advisors holds 103 positions in its portfolio as reported in the June 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Seattle Genetics | 23.5 | $3.5B | 50M | 69.21 | |
| Incyte Corporation (INCY) | 18.5 | $2.7B | 32M | 84.96 | |
| BeiGene Sponsored Adr (BGNE) | 9.9 | $1.5B | 12M | 123.95 | |
| Alexion Pharmaceuticals | 7.4 | $1.1B | 8.3M | 130.98 | |
| ACADIA Pharmaceuticals (ACAD) | 7.1 | $1.1B | 39M | 26.73 | |
| Amarin Corporation Sponsored Adr (AMRN) | 5.5 | $806M | 42M | 19.39 | |
| BioMarin Pharmaceutical (BMRN) | 4.4 | $650M | 7.6M | 85.65 | |
| Genomic Health | 3.7 | $539M | 9.3M | 58.17 | |
| Ascendis Pharma A/S Sponsored Adr (ASND) | 2.7 | $390M | 3.4M | 115.15 | |
| Mirati Therapeutics | 1.8 | $259M | 2.5M | 103.00 | |
| argenx SE Sponsored Adr (ARGX) | 1.0 | $144M | 1.0M | 141.58 | |
| Array BioPharma | 0.9 | $132M | 2.8M | 46.33 | |
| Madrigal Pharmaceuticals (MDGL) | 0.8 | $123M | 1.2M | 104.81 | |
| Neurocrine Biosciences (NBIX) | 0.8 | $120M | 1.4M | 84.43 | |
| Heron Therapeutics (HRTX) | 0.8 | $112M | 6.0M | 18.59 | |
| Kodiak Sciences (KOD) | 0.7 | $107M | 9.1M | 11.70 | |
| Invitae (NVTAQ) | 0.6 | $92M | 3.9M | 23.50 | |
| Tricida | 0.5 | $78M | 2.0M | 39.46 | |
| Spark Therapeutics | 0.5 | $77M | 752k | 102.38 | |
| Atreca CL A Common (BCEL) | 0.5 | $67M | 3.5M | 18.84 | |
| GW Pharmaceuticals Ads | 0.4 | $64M | 371k | 172.39 | |
| Insmed Incorporated Com Par $.01 (INSM) | 0.4 | $63M | 2.5M | 25.60 | |
| Cerus Corporation (CERS) | 0.4 | $60M | 11M | 5.62 | |
| Rhythm Pharmaceuticals (RYTM) | 0.4 | $60M | 2.7M | 22.00 | |
| Principia Biopharma | 0.4 | $59M | 1.8M | 33.19 | |
| Audentes Therapeutics | 0.4 | $57M | 1.5M | 37.86 | |
| Adaptive Biotechnologies Cor (ADPT) | 0.4 | $56M | 1.2M | 48.30 | |
| BioCryst Pharmaceuticals (BCRX) | 0.4 | $55M | 14M | 3.79 | |
| Ra Pharmaceuticals | 0.4 | $54M | 1.8M | 30.07 | |
| Myokardia | 0.3 | $51M | 1.0M | 50.14 | |
| DBV Technologies Sponsored Adr (DBVT) | 0.3 | $45M | 5.5M | 8.22 | |
| Krystal Biotech (KRYS) | 0.3 | $42M | 1.0M | 40.27 | |
| Cymabay Therapeutics | 0.3 | $41M | 5.7M | 7.16 | |
| Neurocrine Biosciences Note 2.25% 5/15/2024 (Principal) | 0.3 | $41M | 31M | 1.32 | |
| uniQure SHS (QURE) | 0.3 | $41M | 518k | 78.15 | |
| Kiniksa Pharmaceuticals Com Cl A (KNSA) | 0.3 | $38M | 2.8M | 13.54 | |
| Zymeworks | 0.3 | $38M | 1.7M | 22.00 | |
| Aquinox Pharmaceuticals | 0.2 | $26M | 11M | 2.36 | |
| Axsome Therapeutics (AXSM) | 0.1 | $20M | 772k | 25.75 | |
| Xencor (XNCR) | 0.1 | $18M | 428k | 40.93 | |
| Merus N V (MRUS) | 0.1 | $17M | 1.2M | 14.65 | |
| BioMarin Pharmaceutical Note 0.599% 8/1/2024 (Principal) | 0.1 | $16M | 15M | 1.04 | |
| Acorda Therapeutics | 0.1 | $15M | 2.0M | 7.67 | |
| La Jolla Pharmaceutical Company Com Par $.0001 2 | 0.1 | $14M | 1.6M | 9.25 | |
| Aimmune Therapeutics | 0.1 | $14M | 674k | 20.82 | |
| Idera Pharmaceuticals Com Par | 0.1 | $12M | 4.6M | 2.67 | |
| Protagonist Therapeutics (PTGX) | 0.1 | $12M | 995k | 12.11 | |
| Marker Therapeutics Ord | 0.1 | $12M | 1.5M | 7.92 | |
| Aeglea Biotherapeutics | 0.1 | $12M | 1.7M | 6.85 | |
| Assembly Biosciences | 0.1 | $11M | 803k | 13.49 | |
| Sangamo Biosciences (SGMO) | 0.1 | $11M | 1000k | 10.77 | |
| Catalyst Pharmaceutical Partners (CPRX) | 0.1 | $9.8M | 2.6M | 3.84 | |
| Syros Pharmaceuticals | 0.1 | $9.0M | 975k | 9.26 | |
| Alkermes SHS (ALKS) | 0.1 | $9.0M | 400k | 22.54 | |
| Dermira | 0.1 | $8.7M | 907k | 9.56 | |
| Albireo Pharma | 0.1 | $8.1M | 250k | 32.24 | |
| Apellis Pharmaceuticals (APLS) | 0.1 | $8.0M | 314k | 25.34 | |
| Milestone Pharmaceuticals (MIST) | 0.0 | $7.2M | 267k | 27.15 | |
| Anaptysbio Inc Common (ANAB) | 0.0 | $6.4M | 113k | 56.42 | |
| Abeona Therapeutics | 0.0 | $6.2M | 1.3M | 4.78 | |
| Hookipa Pharma Inc equity (HOOK) | 0.0 | $6.0M | 893k | 6.73 | |
| Orchard Therapeutics Ads | 0.0 | $5.7M | 406k | 13.99 | |
| Halozyme Therapeutics (HALO) | 0.0 | $5.2M | 300k | 17.18 | |
| Bluebird Bio (BLUE) | 0.0 | $5.1M | 40k | 127.20 | |
| Bellicum Pharma | 0.0 | $4.6M | 2.7M | 1.70 | |
| Menlo Therapeutics | 0.0 | $4.2M | 700k | 5.99 | |
| G1 Therapeutics (GTHX) | 0.0 | $3.9M | 127k | 30.66 | |
| Ngm Biopharmaceuticals (NGM) | 0.0 | $3.7M | 250k | 14.64 | |
| Viking Therapeutics (VKTX) | 0.0 | $3.5M | 425k | 8.30 | |
| Acceleron Pharma | 0.0 | $3.4M | 84k | 41.08 | |
| Crinetics Pharmaceuticals In (CRNX) | 0.0 | $3.3M | 133k | 25.00 | |
| Galapagos NV Sponsored Adr (GLPG) | 0.0 | $3.2M | 25k | 128.95 | |
| Achillion Pharmaceuticals | 0.0 | $2.9M | 1.1M | 2.68 | |
| Aravive | 0.0 | $2.9M | 485k | 6.00 | |
| Xbiotech (XBIT) | 0.0 | $2.9M | 380k | 7.58 | |
| Harpoon Therapeutics | 0.0 | $2.8M | 214k | 13.00 | |
| Forty Seven | 0.0 | $2.7M | 250k | 10.60 | |
| Autolus Therapeutics Sponsored Ads (AUTL) | 0.0 | $2.5M | 157k | 16.10 | |
| Y Mabs Therapeutics (YMAB) | 0.0 | $2.4M | 103k | 22.87 | |
| Cyclerion Therapeutics | 0.0 | $2.3M | 203k | 11.45 | |
| Spring Bk Pharmaceuticals In | 0.0 | $2.3M | 613k | 3.69 | |
| Nextcure (NXTC) | 0.0 | $2.2M | 150k | 14.98 | |
| Cytomx Therapeutics (CTMX) | 0.0 | $2.2M | 194k | 11.22 | |
| Molecular Templates | 0.0 | $2.1M | 254k | 8.35 | |
| Intellia Therapeutics (NTLA) | 0.0 | $2.1M | 129k | 16.37 | |
| Ideaya Biosciences (IDYA) | 0.0 | $2.0M | 200k | 9.96 | |
| Chemocentryx | 0.0 | $1.9M | 207k | 9.30 | |
| Constellation Pharmceticls I | 0.0 | $1.6M | 133k | 12.28 | |
| Galmed Pharmaceuticals SHS | 0.0 | $1.6M | 216k | 7.35 | |
| Aileron Therapeutics | 0.0 | $1.5M | 2.0M | 0.72 | |
| Dova Pharmaceuticals | 0.0 | $1.4M | 99k | 14.10 | |
| Foamix Pharmaceuticals SHS | 0.0 | $1.2M | 498k | 2.38 | |
| Sierra Oncology | 0.0 | $1.1M | 2.0M | 0.56 | |
| Adamas Pharmaceuticals | 0.0 | $1.1M | 173k | 6.20 | |
| Infinity Pharmaceuticals (INFIQ) | 0.0 | $1.0M | 580k | 1.80 | |
| Arcus Biosciences Incorporated (RCUS) | 0.0 | $966k | 122k | 7.95 | |
| Fulgent Genetics (FLGT) | 0.0 | $835k | 125k | 6.68 | |
| Affimed Therapeutics B V | 0.0 | $574k | 200k | 2.87 | |
| Aquestive Therapeutics (AQST) | 0.0 | $418k | 100k | 4.20 | |
| Sunesis Pharmaceuticals Com Par | 0.0 | $405k | 557k | 0.73 | |
| Ritter Pharmaceuticals | 0.0 | $300k | 280k | 1.07 | |
| Dynavax Technologies (DVAX) | 0.0 | $299k | 75k | 3.99 | |
| Trillium Therapeutics, Inc. Cmn | 0.0 | $166k | 505k | 0.33 |
